Literature DB >> 30278284

Mechanisms of persistence by small DNA tumor viruses.

Nathan A Krump1, Wei Liu1, Jianxin You2.   

Abstract

Virus infection contributes to nearly 15% of human cancers worldwide. Many of the oncogenic viruses tend to cause cancer in immunosuppressed individuals, but maintain asymptomatic, persistent infection for decades in the general population. In this review, we discuss the tactics employed by two small DNA tumor viruses, Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV), to establish persistent infection. We will also highlight recent key findings as well as outstanding questions regarding the mechanisms by which HPV and MCPyV evade host immune control to promote their survival. Since persistent infection enables virus-induced tumorigenesis, identifying the mechanisms by which small DNA tumor viruses achieve latent infection may inform new approaches for preventing and treating their respective human cancers.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30278284      PMCID: PMC6263785          DOI: 10.1016/j.coviro.2018.09.002

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  119 in total

1.  Variations in the association of papillomavirus E2 proteins with mitotic chromosomes.

Authors:  Jaquelline G Oliveira; Leremy A Colf; Alison A McBride
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-13       Impact factor: 11.205

2.  Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation.

Authors:  C W Lehman; M R Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

Review 3.  Mechanisms and strategies of papillomavirus replication.

Authors:  Alison A McBride
Journal:  Biol Chem       Date:  2017-07-26       Impact factor: 3.915

Review 4.  Reviewing the current evidence supporting early B-cells as the cellular origin of Merkel cell carcinoma.

Authors:  C M Sauer; A M Haugg; E Chteinberg; D Rennspiess; V Winnepenninckx; E-J Speel; J C Becker; A K Kurz; A Zur Hausen
Journal:  Crit Rev Oncol Hematol       Date:  2017-06-03       Impact factor: 6.312

5.  High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome.

Authors:  Antoine Touzé; Emmanuelle Le Bidre; Hélène Laude; Maxime J J Fleury; Raphaël Cazal; Françoise Arnold; Agnès Carlotti; Eve Maubec; François Aubin; Marie-Françoise Avril; Flore Rozenberg; Mauro Tognon; Annabel Maruani; Serge Guyetant; Gérard Lorette; Pierre Coursaget
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544

6.  High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.

Authors:  Jeanette Reiser; José Hurst; Maike Voges; Peter Krauss; Peter Münch; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

7.  Quantitation of human seroresponsiveness to Merkel cell polyomavirus.

Authors:  Diana V Pastrana; Yanis L Tolstov; Jürgen C Becker; Patrick S Moore; Yuan Chang; Christopher B Buck
Journal:  PLoS Pathog       Date:  2009-09-11       Impact factor: 6.823

8.  Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation.

Authors:  Jing Li; Xin Wang; Jason Diaz; Sabrina H Tsang; Christopher B Buck; Jianxin You
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

9.  Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes.

Authors:  Joseph J Carter; Matthew D Daugherty; Xiaojie Qi; Anjali Bheda-Malge; Gregory C Wipf; Kristin Robinson; Ann Roman; Harmit S Malik; Denise A Galloway
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-11       Impact factor: 11.205

Review 10.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors:  Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal:  Lancet Oncol       Date:  2012-05-09       Impact factor: 41.316

View more
  8 in total

Review 1.  Human polyomavirus modulation of the host DNA damage response.

Authors:  Danyal Tahseen; Peter L Rady; Stephen K Tyring
Journal:  Virus Genes       Date:  2020-01-29       Impact factor: 2.332

Review 2.  Control of Viral Latency by Episome Maintenance Proteins.

Authors:  Alessandra De Leo; Abram Calderon; Paul M Lieberman
Journal:  Trends Microbiol       Date:  2019-10-14       Impact factor: 17.079

Review 3.  The Double-Edged Sword-How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer.

Authors:  Hao-Fan Wang; Sha-Sha Wang; Ya-Jie Tang; Yu Chen; Min Zheng; Ya-Ling Tang; Xin-Hua Liang
Journal:  Front Immunol       Date:  2019-04-02       Impact factor: 7.561

4.  Expression of p16, p53, and TLR9 in HPV-Associated Head and Neck Squamous Cell Carcinoma: Clinicopathological Correlations and Potential Prognostic Significance.

Authors:  Shu Wang; Xibing Zhuang; Caixia Gao; Tiankui Qiao
Journal:  Onco Targets Ther       Date:  2021-02-05       Impact factor: 4.147

5.  Association between oncogenic human papillomavirus type 16 and Killian polyp.

Authors:  Lucia Oton-Gonzalez; John Charles Rotondo; Luca Cerritelli; Nicola Malagutti; Carmen Lanzillotti; Ilaria Bononi; Andrea Ciorba; Chiara Bianchini; Chiara Mazziotta; Monica De Mattei; Stefano Pelucchi; Mauro Tognon; Fernanda Martini
Journal:  Infect Agent Cancer       Date:  2021-01-07       Impact factor: 2.965

Review 6.  Is the ZIKV Congenital Syndrome and Microcephaly Due to Syndemism with Latent Virus Coinfection?

Authors:  Solène Grayo
Journal:  Viruses       Date:  2021-04-13       Impact factor: 5.048

Review 7.  Emerging role of human polyomaviruses 6 and 7 in human cancers.

Authors:  Ghalib Mobaraki; Dan Liu; Faisal Klufah; Raed A Alharbi; Anna Kordelia Kurz; Ernst Jan M Speel; Véronique Winnepenninckx; Axel Zur Hausen
Journal:  Infect Agent Cancer       Date:  2021-05-17       Impact factor: 2.965

Review 8.  The Role of Histone Post-Translational Modifications in Merkel Cell Carcinoma.

Authors:  Chiara Mazziotta; Carmen Lanzillotti; Roberta Gafà; Antoine Touzé; Marie-Alice Durand; Fernanda Martini; John Charles Rotondo
Journal:  Front Oncol       Date:  2022-03-08       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.